©2020 Alcon Inc. 11/20 US-DCV-2000001
See product instructions for DuoVisc® Viscoelastic System and DisCoVisc® OVD
important product information
references
DisCoVisc®OVD
DuoVisc®Viscoelastic System
PRODUCT DETAILS
99.2
%
Space maintenance during capsulorhexis, and IOL insertion phases
chamber maintenance during capsulotomy
vs 30.6% when using competitor
full space maintenance during IOL insertion
vs 47.9% when using competitor*
*Competitor is Healon
Visualization during the surgical procedure
excellent or good visualization during the surgical procedure
vs 88.1% when using competitor
Retention during lens removal (phaco) phase
at 6mL/min aspiration rate
vs 0 μ when using competitors
EXCELLENCE AT EACH STAGE
IMPORTANT PRODUCT INFORMATION
REFERENCES
DisCoVisc®OVD, the first and only viscous dispersive, provides the flexibility of both cohesive and dispersive properties in a single syringe. Its chemical and mechanical design provides genuine endothelial protection, as well as better access and clarity.
DisCoVisc®OVD
The First Viscous Dispersive
ONE VISCOELASTIC.
FULL PROCEDURE.
Excellent clarity and easy removal
High molecular weight to maximize space maintenance in the anterior chamber and capsular bag
IMPORTANT PRODUCT INFORMATION
PROVISC®OVD for Mechanical Protection and Space Maintenance
Retention During Phacoemulsification
DisCoVisc® OVD and VISCOAT® OVD outranked competitors in OVD retention after phacoemulsification at three flow rates.
Protection from Free Radicals
VISCOAT® OVD outperformed competitors in reduction of free radicals.
PROVEN SUPERIORITY
3
2
Greater binding to corneal endothelium due to two extra negative charges from Chondroitin Sulfate, totaling three negative charges, versus one in most OVDs
4,5
The only dispersive OVD offering the protection of 4% Chondroitin Sulfate
IMPORTANT PRODUCT INFORMATION
VISCOAT®OVD for Proven Protection
DuoVisc®Viscoelastic System offers both the endothelial protection of chondroitin sulfate in VISCOAT®OVD (dispersive) with the proven mechanical protection and space maintenance found in PROVISC®OVD (cohesive).
DuoVisc® Viscoelastic System
IMPORTANT PRODUCT INFORMATION
REFERENCES
ONE SYSTEM. NO COMPROMISES.
PROTECT EFFECTIVELY WITH CHONDROITIN Sulfate
• Better endothelial cell protection
• Superior clarity and visualization
• Superior retention during lens removal
• Superior anterior capsule dome maintenance
• Proven mechanical protection of space maintenance
• Easy to remove after procedure
OVDs with chondroitin sulfate lose viscosity at a slower rate during stress and readily adhere to ocular tissue:
Operate confidently in everyday cases and complex situations
DuoVisc®System
DisCoVisc®OVD
Designed for use through an entire cataract surgery
OPHTHALMIC VISCOSURGICAL DEVICES (OVDs)
Protect What’s Important
Scroll to Learn More
IMPORTANT PRODUCT INFORMATION
REFERENCES
5
6
1-3
7-9
10
1
1,4,6-7
3,7
1
3
3
3
3
4
7-10
11-12
7-12
3,13,14
15-17
9-12
11
12,13
14
1
3
3
10
10
10
3
18,19
20-21
21
4
1
3
3
See product instructions for complete wear, care and safety information
IMPORTANT SAFETY INFORMATION
1. Petroll WM, et al. Quantitative assessment of ophthalmicviscosurgical device retention using invivo confocal microscopy. J Cataract Refract Surg. 2005 Dec;31(12):2363-8.
2. Vasavada A, et al. Protective effect of ophthalmic viscosurgical devices (OVDs) against hydrogen peroxide-induced oxidative damage to corneal endothelial cells: an in-vitro model. Accepted for presentation: American Society of Cataract and Refractive Surgeons; April 3-8, 2--9; SAn Francisco, CA.
3. DisCoVisc®OVD Product Insert
4. Glasser B, et al. Protective Effects of Viscous Solutions in Phacoemulsifaction
5. Poyer J, et al. New Method to measure the retention of viscoelastic agents on a rabbit corneal
6. Lindstrom, et al. Protective Effect of OVDs Against Hydrogen Peroxide-Induced Oxidative Damage
7. Papconstantinou, et al. Clinical trial evaluation Viscoat and Visthesia ophthalmic viscosurgical
References
See product instructions for complete wear, care and safety information
IMPORTANT SAFETY INFORMATION
IMPORTANT PRODUCT INFORMATION
REFERENCES
©2020 Alcon Inc. 11/20 US-DCV-2000001
See product instructions for DuoVisc® Viscoelastic System and DisCoVisc® OVD
important product information
references
DisCoVisc®OVD
DuoVisc®Viscoelastic System
PRODUCT DETAILS
Space maintenance during capsulorhexis, and IOL insertion phases
chamber maintenance during capsulotomy
vs 30.6% when using competitor
full space maintenance during IOL insertion
vs 47.9% when using competitor*
99.2
%
Visualization during the surgical procedure
excellent or good visualization during the surgical procedure
vs 88.1% when using competitor
Retention during lens removal (phaco) phase
vs 0 μ when using competitors
EXCELLENCE AT EACH STAGE
at 6mL/min aspiration rate
IMPORTANT PRODUCT INFORMATION
REFERENCES
DisCoVisc®OVD, the first and only viscous dispersive, provides the flexibility of both cohesive and dispersive properties in a single syringe. Its chemical and mechanical design provides genuine endothelial protection, as well as better access and clarity.
DisCoVisc®OVD
The First Viscous Dispersive
ONE VISCOELASTIC.
FULL PROCEDURE.
Excellent clarity and easy removal
High molecular weight to maximize space maintenance in the anterior chamber and capsular bag
IMPORTANT PRODUCT INFORMATION
PROVISC®OVD for Mechanical Protection and Space Maintenance
Greater binding to corneal endothelium due to two extra negative charges from Chondroitin Sulfate, totaling three negative charges, versus one in most OVDs
4,5
The only dispersive OVD offering the protection of 4% Chondroitin Sulfate
IMPORTANT PRODUCT INFORMATION
VISCOAT®OVD for Proven Protection
DuoVisc®Viscoelastic System offers both the endothelial protection of chondroitin sulfate in VISCOAT®OVD (dispersive) with the proven mechanical protection and space maintenance found in PROVISC®OVD (cohesive).
DuoVisc® Viscoelastic System
IMPORTANT PRODUCT INFORMATION
REFERENCES
ONE SYSTEM. NO COMPROMISES.
1,4,6-7
3.7
1
3
3
3
• Better endothelial cell protection
• Superior clarity and visualization
• Superior retention during lens removal
• Superior anterior capsule dome maintenance
• Proven mechanical protection of space maintenance
• Easy to remove after procedure
OVDs with chondroitin sulfate lose viscosity at a slower rate during stress and readily adhere to ocular tissue:
Operate confidently in everyday cases and complex situations
DuoVisc®System
DisCoVisc®OVD
PROTECT EFFECTIVELY WITH CHONDROITIN
Designed for use through an entire cataract surgery
OPHTHALMIC VISCOSURGICAL DEVICES (OVDs)
Protect What’s Important
Scroll to Learn More
IMPORTANT PRODUCT INFORMATION
REFERENCES
5
6
1-3
7-9
10
1
4
7-10
11-12
7-12
3,13,14
15-17
9-12
11
12,13
14
1
3
3
Retention During Phacoemulsification
DisCoVisc® OVD and VISCOAT® OVD outranked competitors in OVD retention after phacoemulsification at three flow rates.
Protection from Free Radicals
VISCOAT® OVD outperformed competitors in reduction of free radicals.
PROVEN SUPERIORITY
3
2
10
10
10
3
18,19
20-21
21
4
1
3
3
3
See product instructions for complete wear, care and safety information
IMPORTANT SAFETY INFORMATION
1. Petroll WM, et al. Quantitative assessment of ophthalmicviscosurgical device retention using invivo confocal microscopy. J Cataract Refract Surg. 2005 Dec;31(12):2363-8.
2. Vasavada A, et al. Protective effect of ophthalmic viscosurgical devices (OVDs) against hydrogen peroxide-induced oxidative damage to corneal endothelial cells: an in-vitro model. Accepted for presentation: American Society of Cataract and Refractive Surgeons; April 3-8, 2--9; SAn Francisco, CA.
3. DisCoVisc®OVD Product Insert
4. Glasser B, et al. Protective Effects of Viscous Solutions in Phacoemulsifaction
5. Poyer J, et al. New Method to measure the retention of viscoelastic agents on a rabbit corneal
6. Lindstrom, et al. Protective Effect of OVDs Against Hydrogen Peroxide-Induced Oxidative Damage
7. Papconstantinou, et al. Clinical trial evaluation Viscoat and Visthesia ophthalmic viscosurgical
References
See product instructions for complete wear, care and safety information
IMPORTANT SAFETY INFORMATION